Researchers at the University of Wisconsin-Madison School of Veterinary Medicine want to determine the efficacy and safety of extracorporeal shock wave therapy (ESWT), and are seeking horses to participate in a study using the therapy.

High Medical Technologies (HMT) was inadvertently omitted from the list of extracorporeal shock wave therapy manufacturers in the May issue of The Horse. The company is based in Switzerland.

HMT High Medical Technologies A.G.

Extracorporeal shock wave therapy (ESWT) is an established medical treatment (see The Horse of May 2001). Originally utilized to treat human kidney stones non-invasively, additional applications for this technology have been discovered.

The Grayson-Jockey Club Research Foundation Board of Directors recently approved funding for 11 new projects. An additional project will be funded on the properties of extracorporeal shock wave therapy. The Foundation is inviting researchers to

Researchers and clinicians met March 3 in Kentucky to exchange ideas about a treatment that is gaining nationwide attention for its success in healing difficult soft tissue and bone injuries. Extracorporeal shock wave therapy (ESWT) has intrigue

An extracorporeal shock wave therapy device sounds high-tech, and it is. Based on the same technology that is used in human medicine to break up kidney stones, shock wave therapy is being defined, and refined, for use in treating various injurie

A new, non-invasive veterinary treatment utilizing high pressure waves to alleviate equine bone and tendon ailments—including navicular disease and degenerative joint disease of the lower hock joints—was initiated at the